Esther Dyson
Founder @ Way to Wellville
New York, United States
Esther Dyson is a seed investor at Way to Wellville in New York focused on Health Care and Software. Esther Dyson - Founder @ Way to Wellville
- Total investments:
- 93
- Last investment:
- Lead investor:
- 4%
Last updated:
For AI agents: llms.txt
Industries Esther Dyson invests in
Stages Esther Dyson invests in
Countries Esther Dyson invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $300k–$4M
- Angel
- $330k–$2.9M
- Series A
- $1.5M–$16M
Investment Focus
Industry
- Health Care 22 (24%)
- Software 13 (14%)
- Artificial Intelligence 11 (12%)
- Medical 10 (11%)
- Internet 9 (10%)
Stage
- Seed 36 (39%)
- Series A 17 (18%)
- Angel 8 (9%)
- Series B 6 (6%)
- Pre-Seed 5 (5%)
Country
- United States 55 (59%)
- Egypt 2 (2%)
- Canada 2 (2%)
- Russian Federation 2 (2%)
- Kenya 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| NextSense unlocks brain health with real-world data insights and practical, scientific wisdom for daily living. It aims to catalyze brain health in science and culture. The company was founded in 2020 and is headquartered in Mountain View, California. | $16.3M / Series A / Nov 11, 2025 | ||
| The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love. | $5.4M / Seed / Oct 14, 2025 | ||
| Openwater is a startup developing a medical technology system focused on treating diseases at the cellular level. The company's device uses advanced optoelectronics to replace MRI technology. It has LCDs with small pixels to create holographic images that reduce scattering and achieve MRI-like resolution. This helps physicians diagnose andtreat diseases by targeting individual cells without affecting surrounding tissue. | $54M / Venture - Series Unknown / Aug 22, 2024 | ||
| Ezra has created a new way to screen for cancer using full-body MRI technology assisted by Artificial Intelligence. The company's first AI, developed to assist radiologists when interpreting MRI images of the prostate, is an FDA-cleared software as a medical device. | $21M / Series B / Feb 07, 2024 | ||
| Way is a mindful eating app that replaces restrictive diets. | May 30, 2023 | ||
| Boxhub combines e-commerce and logistics, revolutionizing the way shipping containers are traded, transported, and used. By leveraging tech infrastructure and automation, we make the experience for our customers and suppliers faster, cheaper, and more transparent. | $2.7M / Seed / Apr 11, 2022 | ||
| Humanity is a healthcare company that aims to extend the healthspan of humanity. It develops a software application designed to provide information on how to stop the aging process. The company's service allows people to try different interventions and solutions to help move those biomarkers in a positive direction and thus reduce, and in somecases, stop the loss of function and thus the aging damage.Founded in 2019 by Peter Ward and Michael Geer, Humanity is headquartered in Boston, Massachusetts. | $2.5M / Seed / Aug 04, 2021 | ||
| NeuroGeneces is a seed-stage startup focused on improving memory and slowing cognitive decline while we age. We apply cutting-edge research in sleep and neuroscience to enhance the natural memory consolidation processes that occur during sleep. Our EEG-based headband and algorithms synchronize acoustic stimulus to the user’s Slow Oscillations(SOs) during slow wave sleep, which increases the memory recall. | $220K / Pre-Seed / Jun 09, 2021 | ||
| Medesk is an online medical software for clinics, offices, IPS, and private hospitals. They provide medical practice management software, analytics to track your performance, practice management software, and automated tools for communication. Their features include decision-making support, reporting, analytics, and prescribing. Their tools allowfor keeping patients' data. | $600K / Seed / Jun 01, 2021 | ||
| At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us. | $5.5M / Seed / Apr 06, 2021 | ||
| See all 93 investments → | |||
Co-Investors
About Way to Wellville
10-year nonprofit project dedicated to demonstrating the long-term value of investing in health (mental and physical)
Way to Wellville Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Esther Dyson
Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Esther Dyson invest in?
Esther Dyson invests primarily in Health Care, Software and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 93 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Esther Dyson's check size?
Esther Dyson typically joins rounds of $300k–$4M at Seed, $330k–$2.9M at Angel and $1.5M–$16M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Esther Dyson participates in.
How do I contact Esther Dyson?
Public channels for Esther Dyson include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Esther Dyson last invest?
The most recent investment recorded for Esther Dyson closed in Nov 2025. Shizune tracks 93 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
